Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

OP0050 Evolution of the alternative classification of HLA-DRB1 alleles in rheumatoid arthritis: Impact on the production of the anti-citrullinated protein antibodies and structural progression, data from the ESPOIR cohort

Identifieur interne : 000553 ( France/Analysis ); précédent : 000552; suivant : 000554

OP0050 Evolution of the alternative classification of HLA-DRB1 alleles in rheumatoid arthritis: Impact on the production of the anti-citrullinated protein antibodies and structural progression, data from the ESPOIR cohort

Auteurs : A. Ruyssen-Witrand [France] ; P.-A. Gourraud [États-Unis] ; D. Nigon [France] ; C. Lukas [France] ; C. Miceli-Richard ; B. Jamard ; A. Cantagrel ; A. Cambon-Thomsen [France] ; P. Dieudé [France] ; A. Constantin [France]

Source :

RBID : ISTEX:97DF25D6AF5611F6F1329AACFE509BF40700EEA0

English descriptors

Abstract

Background HLA-DR shared epitope alleles have been previously reclassified in an alternative classification (1) relevant in terms of rheumatoid arthritis (RA) susceptibility, ACPA production and severity. However, subclassification of S2 alleles according to the amino acid at position 70 has never been assessed. Objectives The aim of this work was to validate a modified version of this alternative classification in terms of association with ACPAs production and radiographic progression in a cohort of early RA. We proposed to devise S2 groups into 2 groups (S2D and S2P) according to the amino acid at position 70 and to pool the different alleles in 3 risk groups. Methods 612 patients included in the ESPOIR cohort, fulfilling ACR/EULAR 2009 criteria for RA were genotyped for HLA-DRB1 alleles. Radiographs were centrally read and scored using the Total Sharp/van der Heijde Score (mTSS). The different alleles were classified according to a modified version of the alternative classification (X, S1, S2D, S2P, S3D, S3P) and were pooled according to ACPA production risk: the “L group” for low risk (S1 and X), the “N group” for neutral risk (S2D and S3D), “H group” for high risk (S3P and S2P). The association between the different genotypes and 1) the ACPA positivity was assessed by a Chi square test, 2) the radiographic progression at 12 months by Wilcoxon’s rank sum test. Finally, a logistic regression was used to assess the risk of progression (≥1 mTSS unit). Results The LH, NH and HH genotypes were significantly associated with ACPA positivity (respectively OR[95%CI]=1.92 [1.34-2.75], p=0.0002, OR[95%CI]=1.84 [1.02-3.37], p=0.03, OR[95%CI]=4.83 [2.66-9.20], p<0.0001), whereas LL genotype had a protective effect (OR[95%CI]=0.18 [0.11-0.28], p<0.0001). LH and HH genotypes were associated with structural progression (respectively p=0.0067 and p<0.0001) whereas LL and LN genotypes seemed to have a protective effect on progression (respectively p<0.0001 and p=0.0151). H allele carriage was significantly associated with progression in the multivariate model independently of ACPA status (OR [95%CI]=1.90 [1.08-3.35], p=0.026). Conclusions Pooling alleles in 3 risk groups simplify the alternative classification of HLA-DRB1 alleles and is relevant in terms of association with ACPA production and radiographic progression. References du Montcel ST, Michou L, Petit-Teixeira E, Osorio J, Lemaire I, Lasbleiz S, Pierlot C, Quillet P, Bardin T, Prum B, et al: New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis Rheum 2005, 52:1063-1068. Disclosure of Interest None Declared

Url:
DOI: 10.1136/annrheumdis-2012-eular.1733


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:97DF25D6AF5611F6F1329AACFE509BF40700EEA0

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">OP0050 Evolution of the alternative classification of HLA-DRB1 alleles in rheumatoid arthritis: Impact on the production of the anti-citrullinated protein antibodies and structural progression, data from the ESPOIR cohort</title>
<author>
<name sortKey="Ruyssen Witrand, A" sort="Ruyssen Witrand, A" uniqKey="Ruyssen Witrand A" first="A." last="Ruyssen-Witrand">A. Ruyssen-Witrand</name>
</author>
<author>
<name sortKey="Gourraud, P A" sort="Gourraud, P A" uniqKey="Gourraud P" first="P.-A." last="Gourraud">P.-A. Gourraud</name>
</author>
<author>
<name sortKey="Nigon, D" sort="Nigon, D" uniqKey="Nigon D" first="D." last="Nigon">D. Nigon</name>
</author>
<author>
<name sortKey="Lukas, C" sort="Lukas, C" uniqKey="Lukas C" first="C." last="Lukas">C. Lukas</name>
</author>
<author>
<name sortKey="Miceli Richard, C" sort="Miceli Richard, C" uniqKey="Miceli Richard C" first="C." last="Miceli-Richard">C. Miceli-Richard</name>
</author>
<author>
<name sortKey="Jamard, B" sort="Jamard, B" uniqKey="Jamard B" first="B." last="Jamard">B. Jamard</name>
</author>
<author>
<name sortKey="Cantagrel, A" sort="Cantagrel, A" uniqKey="Cantagrel A" first="A." last="Cantagrel">A. Cantagrel</name>
</author>
<author>
<name sortKey="Cambon Thomsen, A" sort="Cambon Thomsen, A" uniqKey="Cambon Thomsen A" first="A." last="Cambon-Thomsen">A. Cambon-Thomsen</name>
</author>
<author>
<name sortKey="Dieude, P" sort="Dieude, P" uniqKey="Dieude P" first="P." last="Dieudé">P. Dieudé</name>
</author>
<author>
<name sortKey="Constantin, A" sort="Constantin, A" uniqKey="Constantin A" first="A." last="Constantin">A. Constantin</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:97DF25D6AF5611F6F1329AACFE509BF40700EEA0</idno>
<date when="2013" year="2013">2013</date>
<idno type="doi">10.1136/annrheumdis-2012-eular.1733</idno>
<idno type="url">https://api.istex.fr/ark:/67375/NVC-5MPN0HXQ-0/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000736</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000736</idno>
<idno type="wicri:Area/Istex/Curation">000736</idno>
<idno type="wicri:Area/Istex/Checkpoint">000814</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000814</idno>
<idno type="wicri:doubleKey">0003-4967:2013:Ruyssen Witrand A:op:evolution:of</idno>
<idno type="wicri:Area/Main/Merge">002D37</idno>
<idno type="wicri:Area/Main/Curation">002D23</idno>
<idno type="wicri:Area/Main/Exploration">002D23</idno>
<idno type="wicri:Area/France/Extraction">000553</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">OP0050 Evolution of the alternative classification of HLA-DRB1 alleles in rheumatoid arthritis: Impact on the production of the anti-citrullinated protein antibodies and structural progression, data from the ESPOIR cohort</title>
<author>
<name sortKey="Ruyssen Witrand, A" sort="Ruyssen Witrand, A" uniqKey="Ruyssen Witrand A" first="A." last="Ruyssen-Witrand">A. Ruyssen-Witrand</name>
<affiliation wicri:level="4">
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology, Purpan Hospital, Inserm Umr 1027; Université Paul Sabatier, Toulouse</wicri:regionArea>
<placeName>
<region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
<orgName type="university">Université Toulouse III - Paul Sabatier</orgName>
</affiliation>
<affiliation wicri:level="4">
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology, Purpan Hospital, Inserm Umr 1027; Université Paul Sabatier, Toulouse</wicri:regionArea>
<placeName>
<region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
<orgName type="university">Université Toulouse III - Paul Sabatier</orgName>
</affiliation>
</author>
<author>
<name sortKey="Gourraud, P A" sort="Gourraud, P A" uniqKey="Gourraud P" first="P.-A." last="Gourraud">P.-A. Gourraud</name>
<affiliation wicri:level="3">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, University of California, San Francisco</wicri:regionArea>
<placeName>
<settlement type="city">San Francisco</settlement>
<region type="state">Californie</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, University of California, San Francisco</wicri:regionArea>
<placeName>
<settlement type="city">San Francisco</settlement>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nigon, D" sort="Nigon, D" uniqKey="Nigon D" first="D." last="Nigon">D. Nigon</name>
<affiliation wicri:level="3">
<country>France</country>
<placeName>
<settlement type="city">Toulouse</settlement>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
</placeName>
<wicri:orgArea>Purpan Hospital</wicri:orgArea>
</affiliation>
<affiliation wicri:level="3">
<country>France</country>
<placeName>
<settlement type="city">Toulouse</settlement>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
</placeName>
<wicri:orgArea>Purpan Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Lukas, C" sort="Lukas, C" uniqKey="Lukas C" first="C." last="Lukas">C. Lukas</name>
<affiliation wicri:level="3">
<country>France</country>
<placeName>
<settlement type="city">Montpellier</settlement>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
<wicri:orgArea>Department of Rheumatology, Hopital Lapeyronie</wicri:orgArea>
</affiliation>
<affiliation wicri:level="3">
<country>France</country>
<placeName>
<settlement type="city">Montpellier</settlement>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
</placeName>
<wicri:orgArea>Department of Rheumatology, Hopital Lapeyronie</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Miceli Richard, C" sort="Miceli Richard, C" uniqKey="Miceli Richard C" first="C." last="Miceli-Richard">C. Miceli-Richard</name>
<affiliation></affiliation>
<affiliation>
<wicri:noCountry code="subField">Bicêtre</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Jamard, B" sort="Jamard, B" uniqKey="Jamard B" first="B." last="Jamard">B. Jamard</name>
<affiliation></affiliation>
<affiliation>
<wicri:noCountry code="subField">Hospital</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Cantagrel, A" sort="Cantagrel, A" uniqKey="Cantagrel A" first="A." last="Cantagrel">A. Cantagrel</name>
<affiliation></affiliation>
<affiliation>
<wicri:noCountry code="subField">Hospital</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Cambon Thomsen, A" sort="Cambon Thomsen, A" uniqKey="Cambon Thomsen A" first="A." last="Cambon-Thomsen">A. Cambon-Thomsen</name>
<affiliation wicri:level="3">
<country>France</country>
<placeName>
<settlement type="city">Toulouse</settlement>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
</placeName>
<wicri:orgArea>Inserm Umr 1027, Université Paul Sabatier</wicri:orgArea>
</affiliation>
<affiliation wicri:level="3">
<country>France</country>
<placeName>
<settlement type="city">Toulouse</settlement>
<region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
</placeName>
<wicri:orgArea>Inserm Umr 1027, Université Paul Sabatier</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Dieude, P" sort="Dieude, P" uniqKey="Dieude P" first="P." last="Dieudé">P. Dieudé</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology, Hôpital Bichat-Claude Bernard, INSERM U699, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology, Hôpital Bichat-Claude Bernard, INSERM U699, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Constantin, A" sort="Constantin, A" uniqKey="Constantin A" first="A." last="Constantin">A. Constantin</name>
<affiliation wicri:level="4">
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology, Purpan Hospital, Inserm Umr 1027; Université Paul Sabatier, Toulouse</wicri:regionArea>
<placeName>
<region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
<orgName type="university">Université Toulouse III - Paul Sabatier</orgName>
</affiliation>
<affiliation wicri:level="4">
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology, Purpan Hospital, Inserm Umr 1027; Université Paul Sabatier, Toulouse</wicri:regionArea>
<placeName>
<region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
<orgName type="university">Université Toulouse III - Paul Sabatier</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Annals of the Rheumatic Diseases</title>
<title level="j" type="abbrev">Ann Rheum Dis</title>
<idno type="ISSN">0003-4967</idno>
<idno type="eISSN">1468-2060</idno>
<imprint>
<publisher>BMJ Publishing Group Ltd and European League Against Rheumatism</publisher>
<date type="published" when="2013-06">2013-06</date>
<biblScope unit="volume">71</biblScope>
<biblScope unit="issue">Suppl 3</biblScope>
<biblScope unit="page" from="70">70</biblScope>
</imprint>
<idno type="ISSN">0003-4967</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0003-4967</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acpa</term>
<term>Acpa positivity</term>
<term>Acpa production</term>
<term>Allele</term>
<term>Amino acid</term>
<term>Biogen idec</term>
<term>Biosci</term>
<term>Cohort</term>
<term>Cresc</term>
<term>Different alleles</term>
<term>Disease duration</term>
<term>Early synovitis</term>
<term>Espoir cohort</term>
<term>Genotype</term>
<term>Joint damage</term>
<term>Last tocilizumab administration</term>
<term>Paul sabatier</term>
<term>Persistent disease</term>
<term>Positivity</term>
<term>Predictor</term>
<term>Progression</term>
<term>Protective effect</term>
<term>Purpan hospital</term>
<term>Radiographic</term>
<term>Radiographic progression</term>
<term>Remission</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatology</term>
<term>Risk groups</term>
<term>Serological markers</term>
<term>Seropositivity</term>
<term>Structural progression</term>
<term>Synovitis</term>
<term>Tocilizumab</term>
<term>Ultrasound</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Background HLA-DR shared epitope alleles have been previously reclassified in an alternative classification (1) relevant in terms of rheumatoid arthritis (RA) susceptibility, ACPA production and severity. However, subclassification of S2 alleles according to the amino acid at position 70 has never been assessed. Objectives The aim of this work was to validate a modified version of this alternative classification in terms of association with ACPAs production and radiographic progression in a cohort of early RA. We proposed to devise S2 groups into 2 groups (S2D and S2P) according to the amino acid at position 70 and to pool the different alleles in 3 risk groups. Methods 612 patients included in the ESPOIR cohort, fulfilling ACR/EULAR 2009 criteria for RA were genotyped for HLA-DRB1 alleles. Radiographs were centrally read and scored using the Total Sharp/van der Heijde Score (mTSS). The different alleles were classified according to a modified version of the alternative classification (X, S1, S2D, S2P, S3D, S3P) and were pooled according to ACPA production risk: the “L group” for low risk (S1 and X), the “N group” for neutral risk (S2D and S3D), “H group” for high risk (S3P and S2P). The association between the different genotypes and 1) the ACPA positivity was assessed by a Chi square test, 2) the radiographic progression at 12 months by Wilcoxon’s rank sum test. Finally, a logistic regression was used to assess the risk of progression (≥1 mTSS unit). Results The LH, NH and HH genotypes were significantly associated with ACPA positivity (respectively OR[95%CI]=1.92 [1.34-2.75], p=0.0002, OR[95%CI]=1.84 [1.02-3.37], p=0.03, OR[95%CI]=4.83 [2.66-9.20], p<0.0001), whereas LL genotype had a protective effect (OR[95%CI]=0.18 [0.11-0.28], p<0.0001). LH and HH genotypes were associated with structural progression (respectively p=0.0067 and p<0.0001) whereas LL and LN genotypes seemed to have a protective effect on progression (respectively p<0.0001 and p=0.0151). H allele carriage was significantly associated with progression in the multivariate model independently of ACPA status (OR [95%CI]=1.90 [1.08-3.35], p=0.026). Conclusions Pooling alleles in 3 risk groups simplify the alternative classification of HLA-DRB1 alleles and is relevant in terms of association with ACPA production and radiographic progression. References du Montcel ST, Michou L, Petit-Teixeira E, Osorio J, Lemaire I, Lasbleiz S, Pierlot C, Quillet P, Bardin T, Prum B, et al: New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis Rheum 2005, 52:1063-1068. Disclosure of Interest None Declared</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
<li>Languedoc-Roussillon</li>
<li>Midi-Pyrénées</li>
<li>Occitanie (région administrative)</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Montpellier</li>
<li>Paris</li>
<li>San Francisco</li>
<li>Toulouse</li>
</settlement>
<orgName>
<li>Université Toulouse III - Paul Sabatier</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Cantagrel, A" sort="Cantagrel, A" uniqKey="Cantagrel A" first="A." last="Cantagrel">A. Cantagrel</name>
<name sortKey="Jamard, B" sort="Jamard, B" uniqKey="Jamard B" first="B." last="Jamard">B. Jamard</name>
<name sortKey="Miceli Richard, C" sort="Miceli Richard, C" uniqKey="Miceli Richard C" first="C." last="Miceli-Richard">C. Miceli-Richard</name>
</noCountry>
<country name="France">
<region name="Occitanie (région administrative)">
<name sortKey="Ruyssen Witrand, A" sort="Ruyssen Witrand, A" uniqKey="Ruyssen Witrand A" first="A." last="Ruyssen-Witrand">A. Ruyssen-Witrand</name>
</region>
<name sortKey="Cambon Thomsen, A" sort="Cambon Thomsen, A" uniqKey="Cambon Thomsen A" first="A." last="Cambon-Thomsen">A. Cambon-Thomsen</name>
<name sortKey="Cambon Thomsen, A" sort="Cambon Thomsen, A" uniqKey="Cambon Thomsen A" first="A." last="Cambon-Thomsen">A. Cambon-Thomsen</name>
<name sortKey="Constantin, A" sort="Constantin, A" uniqKey="Constantin A" first="A." last="Constantin">A. Constantin</name>
<name sortKey="Constantin, A" sort="Constantin, A" uniqKey="Constantin A" first="A." last="Constantin">A. Constantin</name>
<name sortKey="Dieude, P" sort="Dieude, P" uniqKey="Dieude P" first="P." last="Dieudé">P. Dieudé</name>
<name sortKey="Dieude, P" sort="Dieude, P" uniqKey="Dieude P" first="P." last="Dieudé">P. Dieudé</name>
<name sortKey="Lukas, C" sort="Lukas, C" uniqKey="Lukas C" first="C." last="Lukas">C. Lukas</name>
<name sortKey="Lukas, C" sort="Lukas, C" uniqKey="Lukas C" first="C." last="Lukas">C. Lukas</name>
<name sortKey="Nigon, D" sort="Nigon, D" uniqKey="Nigon D" first="D." last="Nigon">D. Nigon</name>
<name sortKey="Nigon, D" sort="Nigon, D" uniqKey="Nigon D" first="D." last="Nigon">D. Nigon</name>
<name sortKey="Ruyssen Witrand, A" sort="Ruyssen Witrand, A" uniqKey="Ruyssen Witrand A" first="A." last="Ruyssen-Witrand">A. Ruyssen-Witrand</name>
</country>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Gourraud, P A" sort="Gourraud, P A" uniqKey="Gourraud P" first="P.-A." last="Gourraud">P.-A. Gourraud</name>
</region>
<name sortKey="Gourraud, P A" sort="Gourraud, P A" uniqKey="Gourraud P" first="P.-A." last="Gourraud">P.-A. Gourraud</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000553 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000553 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:97DF25D6AF5611F6F1329AACFE509BF40700EEA0
   |texte=   OP0050 Evolution of the alternative classification of HLA-DRB1 alleles in rheumatoid arthritis: Impact on the production of the anti-citrullinated protein antibodies and structural progression, data from the ESPOIR cohort
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021